ASPET Study: An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced Non-Small Cell Lung Cancer Harbouring EGFR Activating Mutations
Clinical trial NCT01723878 · COMPLETED
Trial details
- NCT number
- NCT01723878
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-12-30
- Primary completion
- 2017-06-20
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.